760 related articles for article (PubMed ID: 16502638)
1. [Multicenter study of fungemia due to yeasts in Argentina].
Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
[TBL] [Abstract][Full Text] [Related]
2. Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.
Córdoba S; Vivot W; Bosco-Borgeat ME; Taverna C; Szusz W; Murisengo O; Isla G; Davel G;
Rev Argent Microbiol; 2011; 43(3):176-85. PubMed ID: 22430989
[TBL] [Abstract][Full Text] [Related]
3. Yeasts species distribution in Neonatal Intensive Care Units in northeast Argentina.
Giusiano GE; Mangiaterra M; Rojas F; Gómez V
Mycoses; 2004 Aug; 47(7):300-3. PubMed ID: 15310334
[TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
5. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
[TBL] [Abstract][Full Text] [Related]
6. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
7. Etiology of fungaemia and catheter colonisation in Argentinean paediatric patients.
Giusiano G; Mangiaterra M; Saito VG; Rojas F; Gómez V; Díaz MC
Mycoses; 2006 Jan; 49(1):49-54. PubMed ID: 16367819
[TBL] [Abstract][Full Text] [Related]
8. [A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Rodríguez-Tudela JL; Cuenca-Estrella M
Rev Clin Esp; 1999 Jun; 199(6):356-61. PubMed ID: 10432809
[TBL] [Abstract][Full Text] [Related]
9. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of candidemia in a Turkish tertiary care hospital.
Bakir M; Cerikcioglu N; Barton R; Yagci A
APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812
[TBL] [Abstract][Full Text] [Related]
11. [Multicenter study on nosocomial candidiasis in the Republic of Argentina].
Rodero L; Davel G; Córdoba S; Soria M; Canteros C; Hochenfellner F
Rev Argent Microbiol; 1999; 31(3):114-9. PubMed ID: 10509389
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
13. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
[TBL] [Abstract][Full Text] [Related]
16. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.
Chen TC; Chen YH; Tsai JJ; Peng CF; Lu PL; Chang K; Hsieh HC; Chen TP
J Microbiol Immunol Infect; 2005 Jun; 38(3):200-10. PubMed ID: 15986071
[TBL] [Abstract][Full Text] [Related]
18. Candidemia in neonatal intensive care unit.
Gupta N; Mittal N; Sood P; Kumar S; Kaur R; Mathur MD
Indian J Pathol Microbiol; 2001 Jan; 44(1):45-8. PubMed ID: 12561995
[TBL] [Abstract][Full Text] [Related]
19. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
Khan ZU; Al-Sweih NA; Ahmad S; Al-Kazemi N; Khan S; Joseph L; Chandy R
J Clin Microbiol; 2007 Jun; 45(6):2025-7. PubMed ID: 17428940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
